Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04258943 |
Recruitment Status :
Active, not recruiting
First Posted : February 6, 2020
Last Update Posted : February 22, 2024
|
Sponsor:
Children's Oncology Group
Collaborators:
Erasmus Medical Center
Dutch Childhood Oncology Group
Innovative Therapies for Children with Cancer
Pfizer
Information provided by (Responsible Party):
Children's Oncology Group
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | July 2028 |
Estimated Study Completion Date : | July 2028 |